Crossmark

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy

Crossref DOI link: https://doi.org/10.1186/s12885-016-2363-5

Published Online: 2016-05-24

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Yanqing

Xu, Fan

Pan, Jiahua

Zhu, Yinjie

Shao, Xiaoguang

Sha, Jianjun

Wang, Zezhou

Cai, Yong

Liu, Qiang

Dong, Baijun

Xue, Wei

Huang, Yiran
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (CN) (91129725)

National Natural Science Foundation of China (CN) (81572536)

Science and Technology Commission of Shanghai Municipality (CN) (14140901700)

Shanghai Municipal Education Commission (15ZZ058)

Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai (PWZxq2014-05)

the Joint research foundation of Shanghai Shenkang hospital development center on innovative medical technology (SHDC12015125)

Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20152215)

the Shanghai Jiao Tong University School of Medicine Translational Research Innovation Fund (15ZH4002)